MapLight Therapeutics, Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for MapLight Therapeutics, Inc. (MPLT) is 248.92M

According to MapLight Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 248.92M. This represents a change of -74.23% compared to the average of 965.80M of the last 4 quarters.

MapLight Therapeutics, Inc. (MPLT) Historical Enterprise Value (quarterly & annually)

How has MPLT Enterprise Value performed in the past?

The mean historical Enterprise Value of MapLight Therapeutics, Inc. over the last ten years is 721.27M. The current 248.92M Enterprise Value has changed -65.49% with respect to the historical average. Over the past ten years (40 quarters), MPLT's Enterprise Value was at its highest in in the June 2026 quarter at 1.56B. The Enterprise Value was at its lowest in in the June 2024 quarter at 0.

MapLight Therapeutics, Inc. (MPLT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of MapLight Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

MapLight Therapeutics, Inc. (MPLT) Average Enterprise Value

How has MPLT Enterprise Value performed in the past?

The current Enterprise Value of MapLight Therapeutics, Inc. (MPLT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

MapLight Therapeutics, Inc. (MPLT) Enterprise Value vs. Peers

How is MPLT’s Enterprise Value compared to its peers?

MapLight Therapeutics, Inc.’s Enterprise Value is less than Rapport Therapeutics, Inc. Common Stock (1.16B), less than Alto Neuroscience, Inc. (652.15M), less than Zevra Therapeutics, Inc. (453.87M), greater than Neumora Therapeutics, Inc. Common Stock (-33725858.00), less than GH Research PLC (1.07B), less than Mind Medicine (MindMed) Inc. (4.13B), greater than Minerva Neurosciences, Inc. (89.23M), less than Ovid Therapeutics Inc. (478.89M), greater than Anavex Life Sciences Corp. (-10983057.00), less than LB Pharmaceuticals Inc Common Stock (1.00B),

Build a custom stock screener for MapLight Therapeutics, Inc. (MPLT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MapLight Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MapLight Therapeutics, Inc. (MPLT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MapLight Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.